ABBOTT LABORATORIES — Director's Dealing 2014

Oct 30, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2014-10-28

Reporting Person: WHITE MILES D (Director, Chairman and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-10-28	Common shares without par value	M	402766	$22.267	Acquired	1817291	Direct
2014-10-28	Common shares without par value	S	12959	$42.5050	Disposed	1804332	Direct
2014-10-28	Common shares without par value	S	5700	$42.5025	Disposed	1798632	Direct
2014-10-28	Common shares without par value	S	384107	$42.50	Disposed	1414525	Direct
2014-10-29	Common shares without par value	M	38034	$22.2670	Acquired	1452559	Direct
2014-10-29	Common shares without par value	S	38034	$42.70	Disposed	1414525	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-10-28	Option (right to buy)	$22.267	M	402766	Disposed	2015-02-17	Common shares (402766)	Direct
2014-10-29	Option (right to buy)	$22.2670	M	38034	Disposed	2015-02-17	Common shares (38034)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	26838	Indirect
Common shares without par value	7863	Indirect
Common shares without par value	7772	Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of October 28, 2014.

F2: The reporting person disclaims beneficial ownership of all securities held by his son.

F3: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.